New Colorimetric Micromethod for the Estimation of γ-Glutamyl Transpeptidase Activity in Biological Samples by SWINNEN, J.
Swinnen: Estimation of y-Glutamyl Transpeptidase 557
Z. klin. Chem. u. klin. Biochem.
8. Jg., S. 557—563, November 1970
New Colorimetric Micromethod for the Estimation of -Glutamyl
Transpeptidase Activity in Biological Samples
By J. SWINNEN
From the Department of Clinical Chemistry·, Institute B tinge > Berchem (Anhverp)^ Belgium
(Eingegangen am 19. Mai 1970)
A new colorimetric micromethod for the estimation of y-glutamyl transpeptidase activity has been developed, in order to obtain more
reliable results with greater ease on smaller samples of a wider variety. Enzyme activity can be determined on 0.1 m/ of serum or less, or
the equivalent of spinal fluid or tissue extracts, because the precipitation of proteins has been omitted.
Therefore, correction for possible losses of the reaction product, -naphthylaminc, is no longer necessary and the chromogen can be
diluted without the risk of turbidity, thus permitting the estimation of very low, as well very high enzyme activities. The method utilizes
2 different substrates, designed to determine peptidase and transpeptidase activity, respectively, the differentiation of which is of empirical
significance.
The clinical results suggests that y-glutamyl transpeptidase is a common name for a group of enzymes, some of which occur in an in-
soluble microsomal form, others in a soluble form. There is good evidence that the increased activation by glycylglycine is the result of
an increased conversion of the microsomal enzyme to the soluble form and that the transpeptidation activity increases more readily than
the peptidase.
Es wurde eine neue kolorirnetrische Mikromethode zur Bestimmung von y-Glutamyltranspeptidase entwickelt, um zuverlässigere Er-
gebnisse an kleineren Proben verschiedenster Herkunft einfacher zu erhalten. Die Enzymaktivität kann in 0,1 m/ oder weniger Serum
bzw. der analogen Menge Liquor cerebrospinalis oder Gewebsextrakt bestimmt werden, wobei die Proteinfällung weggelassen wurde.
Aus diesen Gründen ist eine Korrektur für mögliche Verluste des Reaktionsproduktes -Naphthylamin nicht mehr erforderlich; das
Chromogen kann ohne Gefahr der Trübung verdünnt werden, was die Bestimmung sehr geringer als auch sehr hoher Enzymaktivitäten
gestattet. Die Methode benutzt zwei Substrate, um Peptidase- und Transpeptidase-Aktivität zu bestimmen, deren Differenzierung er-
fahrungsgemäß von Bedeutung ist.
Die klinischen Ergebnisse weisen darauf hin, daß y-Glutamyltranspeptidase ein gemeinsamer Name für eine Gruppe von Enzymen ist,
die teils in einer unlöslichen, mikrosomalen Form, teils in löslicher Form vorliegen. Es gibt gute Beweise dafür, daß die zunehmende
Aktivierung durch Glycylglycin das Ergebnis einer zunehmenden Umwandlung des mikrosomalen Enzyms in die lösliche Form ist und
daß die Transpeptidaseaktjvität eher ansteigt als die der Peptidase.
The biological significance of y-glutamyl transpeptidase
is not known; it may play an important role in protein
synthesis (1). The enzyme belongs to the exopeptidases
that cleave the terminal peptide bond, provided that
the glutamyl moiety has a free carboxyl group. In
other words, the enzyme is a carboxy-peptidase. It
has not yet been isolated, despite several attempts
(2, 3, 18). As pointed out by GOLDBARG and coworkers
(4) the terminal glutamyl residue is transferred to
suitable acceptors, particularly peptides but also to
L-amino acids, and even water has been found to act as
an acceptor. Accordingly, one can distinguish three
different types of reactions catalysed by y-glutamyl
transpeptid'ase:
1. Hydrolysis or -glutamyl peptidase activity. In this
reaction the terminal glutamyl residue is split off
hydrolytically as free glutarriic acid (6). The remainder
of the molecule may represent either a peptide, an
amino acid or an amine, the latter being the case with
the present method.
2. Internal transpeptidation. The liberated glutamyl residue
can be transferred to the substrate (5—9), forming a
y-glutamyl-y-glutamyl peptide. Since the present me-
thod uses y-glutamyl-oc-naphthylamide as the in vitro
substrate, "internal transpeptidation" results in y-
glutamyl-y-glutamyl-a-naphthylamide.
Amino acid paper chromatography of the reaction
products has conclusively demonstrated internal trans-
peptidation to represent a significant part of the en-
zymic reaction (17). However, the colorimetric method
described here will, of course, not differentiate between
hydrolysis and internal transpeptidation.
3. External transpeptidation. In the presence of certain
L-amino acids and several di- and tripeptides, the en-
zymic hydrolysis of the terminal glutamyl residue is
coupled with its transfer to L-amino acids or peptides
which act as acceptors (11). This transpeptidation
results in the formation of new y-glutamyl peptides.
Using paper chromatography we could demonstrate
that y-glutamyl-oc-naphthylamide also acts as an acceptor
though to a much lesser degree than glycylglycine,
which is unanimously considered to be the most avid
acceptor for the y-glutamyl moiety.
Using paper chromatography it can be demonstrated
that the three reactions occur simultaneously only in
pancreas extract and in serum. Simple hydrolysis of the
substrate actually occurs in the presence of high con-
centrations of glycylglycine in all the tissue extracts
and tissue fluids studied.
External transpeptidation was observed in all tissue
extracts or tissue fluids, except in kidney extracts,
in which the glycylglycine was too readily hydro-
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lysed and the glycine itself did not act as an acceptor
(17)· . tOur findings are ostensibly in contrast to those of
GOLDBARG and coworkers (4) who employed fresh
rat kidney homogenates and those of SZEWCZUK and
BARANOWSKI (18) using purified beef kidney extract.
Thus far, the determination of y-glutamyl transpepti-
dase activity has been particularly helpful in respect to
the diagnosis of liver diseases (9) and SZCZEKLIK and
coworkers (9) stated rather categorically that "A high
serum y-glutamyl transpeptidase activity, not associated
with jaundice, is a finding very suggestive of a primary
or metastatic liver cancer". In our experience (15, 16),
the determination of the y-glutamyl transpeptidase
activity spans a much wider range of clinical appli-
cability. It permits the differentiation of toxic from
viral liver damage, and intra- or extrahepatic ob-
struction from functional liver insufficiency. In addition,
preliminary studies indicate its diagnostic usefulness in
muscle disorders and intestinal infections. These ob-
servations provided the stimulus to develop the present
micromethod which enables the test to be performed in
the average laboratory at a relatively minor expense.
Methods
The biological sample is incubated at 37° in a buffered solution of
y-glutamyl-a-naphthylamide for 1 to 24 hours, depending on the
respective activity. The liberated α-naphthylamine is diazotized
directly and the concentration of the reaction product determined
colorimetrically. The intensity of the colour is equivalent to the
concentration of α-naphthylamine and therefore to the enzymic
activity. If no acceptor is added, the amount of hydrolysis and/or
internal transpeptidation is measured, whereas if the substrate
solution contains glycylglycine, the color change is predominantly
due to transpeptidation, as shown by paper chromatography(17)
Internal transpeptidation and hydrolysis will also occur with this
substrate, though to a relatively small extent.
Reagents
1. Sfibstrate for determination of hydrolytic activity
y-glutamyl-a-naphthylamide [prepared according the method of
ORLOWSKI and SZEWCZUK (7)] 290 mg.
Tris-(hydroxymethyl)-aminomethane solution O.!M in H2O: 50 m/.
The y-glutamyl-a-nahpthylamide is dissolved in tris buffer by
boiling and after cooling, water is added to make 90 m/. The pH
is then adjusted to 9.0 and more water added to make a volume
of 100 m/.
This solution can be stored for 14 days at 4°. It contains 10 //moles
y-glutamyl-a-naphthylamide/m/.
2. Substrate for determination of transpeptidase activity
y-glutamyl-a-naphthylamide: 290 mg.
Tris-(hydroxymethyl)-aminomethane solution O.!M in H2O: 50 m/.
The solution is prepared as above but before the pH is adjusted to
9.0, 100 mg of glycylglycine are added. The substrate contains
lO^moles y-glutamyl-«-naphthylamide/m/ and 7.5μιηο1ε8 gly-
cylglycine/m/and can also be stored for 2 weeks at 4°.
3. Dia%p reagent
(A) 0.4% sulphanilic acid solution.
0.4 g of sulphanilic acid is dissolved in 6 m/of concentrated
HC1. Water is added to make 100 m/. The solution is stable at
room temperature.
(B) 1% sodium nitrite solution (NaNO2 in water). This solution
must be prepared at least once a week.
(Q Working solution
sulphanilic acid solution (A) 5.0 m/
sodium nitrite solution (B) 0.5 m/
distilled water 14.5 m/
This reagent must be used within 30 minutes after preparation.
4. Dilution fluid
propylene glycol 10 m/ f
methanol p. A. 45 m/
distilled water 45 m/
May be stored indefinitely at room temperature.
5. Standard solution
(A) Stock solution (20 ̂ moles/m/)
288 mg α-naphthylamine (1-amino-naphthalene) is dissolved in
100 m/propylene glycol-water (1:1; v/v).
(B) Working standard $2 pmtAtslml)
The stock solution is diluted 1:100 with propylene glycol water
(1:1; v/v). The standard must be prepared freshly.
Method for serum





































Leave at room temperature for 10 minutes, protected from direct
light. The extinction is measured at 535 nm and the activity ex-
pressed as ̂ moles a-naphthylamine/lOOO m//min at 37° in relation
to the standard solution.
O.D.s
0.04 X 10,000
60 = 6.66 ̂ moles/1000 m//min at 37°.
0.04 == jumol α-naphthylamine in the standard solution.
10,000 = conversion factor for 0.1 m/ to 1000 m/.
60 = time conversion factor.
Technical Results
The method described here is inspired by the tech-
niques of ORLOWSKI and SZEWCZUK (7) and of GOLD-
BARG and coworkers (11). The reaction proceeds at
37°, which is the optimal temperature for serum and
cerebrospinal fluid (15). The activity is expressed in
^moles/1000 m//min at 37° in agreement with OR-
LOWSKI and SZEWCZUK (7).
Our improvements involve three different steps. The-
quantity of the sample is reduced from 0.25 in/to 0.1 ml
(7). This became possible after ommission of the preci-
pitation of protein followed by direct diazotation of the
reaction product after GRIESS (12). The preceding
changes eliminate the necessity to correct for possible
losses of reaction product incurred by the precipitation
of protein. The final step, the dilution of the reaction
mixture after diazotation with the propylene glycol/
methanol/water, permits the determination of very
high enzyme activities without risking turbidity of the
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reaction mixture. Therefore the technique can be
applied to biological samples other than serum, for
example tissue extracts or bacteriological cultures.
Several parameters of the technique have been systemat-
ically examined with the following results:
A. Buffer
According to GOLDBARG and coworkers (4), hydro-
lysis of y-glutamylanilide by rat kidney is highest in a
phosphate buffer at pH 8.7. Nevertheless, these authors
used a veronal buffer (O.lM; pH 8.7) because spon-
taneous hydrolysis of the substrate is very high in
phosphate. Enzymic activity at pH 8.7 is about the
same with borate and veronal buffers, but lower with
glycine and tris buffers. Below pH 4.5, using a phos-
phate-citrate buffer and above pH 10.5 employing a
borate buffer, no enzymic activity was detectable (4).
Transpeptidase activity in serum, using methionine as
acceptor, was about 20% greater in tris buffer (O.lM;
pH 8.7) than in veronal buffer of identical concentration
and pH (11). Using glycylglycine and as buffer and as
acceptor (0.1 IM), the serum y-glutamyl transpeptidase
activity was determined at pH 7.4 (13, 14). .
In agreement with ORLOWSKI and SZEWCZUK (7), we
found a pH maximum of 9.0 for serum and cerebro-
spinal fluid, and the activity was highest with 0.05M
tris buffer (fig. 1). Spontaneous hydrolysis of the








Peptidase and internal transpeptidase (o—o) and transpeptidase (·-
activities in serurri as a function of pH with 0.05M Tris buffer
B. Stability of substrates
At 4°, substrate solution 1 shows a 0.14% hydrolysis
over a period of 14 days and the substrate 2, with the
added glycylglycine, undergoes 0.28% hydrolysis.
After 30 days of storage, hydrolysis increases to 0.40%
and 0.54% respectively. Spontaneous hydrolysis is
enhanced to 1.9% and 2.5% respectively after 14 days
at 37° (fig. 2).
Some bacteria contain a y-glutamyl transferase-like en-
zyme and therefore bacterial contamination renders











Spontaneous hydrolysis of substrate as a function of time and tem-
perature. Curves I and I I I represent the peptidase and curves II and
IV the transpeptidase substrate
C. Stability of the enzyme
Serum and cerebrospinal fluid, taken under sterile
conditions, retain enzyme activity for about 24 hrs at
room temperature (max. loss 3%) and for about 8 days
at 4° G Frozen at —20° C these liquids can be stored for
more than one year without significant loss of enzyme
activity.
D. Enzyme activity and serum dilution —
BEER'S Law
According to GOLDBARG and coworkers (11) enzyme
activity is linearly related to the amount of liberated
<x-naphthylamine, up to 6.7% concentration in the
substrate solution. These authors were forced to use
correction factors for protein concentration which are
difficult to standardize. Nevertheless we could confirm
these observations with our technique, which does not
require deproteinization. More specifically, we found
the quantity of liberated α-naphthylamine to be linear
with the enzyme activity of the serum up to 66 ̂ moles/
1000m//min at 37°, which corresponds to an 8%
hydrolysis of the substrate. Furthermore, the extinction
and concentration of oc-naphthylamine displayed a
linear correspondence (fig. 3). The absorption maxi-
mum lies at 535 nm (fig. 4).
E. Substrate concentration and enzymic
activity
GOLDBARG and coworkers (11) worked with a sub-
strate containing 2.25 ^moles y-glutamyl-anilide per
m/. ORLOWSKI and SZEWCZUK (7) concluded that the
optimal concentration of y-glutamyl-ot-naphthylamide
must be higher than 20 ̂ moles/m/. Such a concen-
tration cannot be achieved because of the limited
solubility of y-glutamyl-cx-naphthylamide. Therefore,
these authors worked with a concentration of
lO/oDoles/m/ in the final test solution. By reducing the
amount of the serum sample and using a substrate
solution with a concentration of 10
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Relation between the calculated colour intensity expressed as O. D.
after dilution and α-naphthylamine concentration, expressed as





Effect of the concentration of y-glutamyl-a-naphthylamide (substrate










of incubation time on enzyme activity in serum (expressed as
, A-naphthylamine/1000 m//min at 37°). The numbers on the
lines will denote the activity of the incubated serum resp. serum
dilution. The relation is linear up to 4 hrs for an activity up to
15 /tmoles/1000 m//min at 37°
y-glutamyl-^-naphthylamide, we obtained a concen-
tration of 8.33 /rnioles y-glutamyl-a-naphthylamide/m/
in the test solution (fig. 5).
F. Incubation time and enzymic activity
Working with an homogenate of rat kidney (0.1 mg/m/),
GOLDBARG and coworkers (4) found a linear relation
between enzyme activity and incubation time up to
4 hrs. The same linear relationship between the extinc-
tion (or calculated enzymic activity) and the incubation
time, was observed in serum for both hydrolysis and
transpeptidation under comparable conditions. Further-
more, we demonstrated a dependency of this linearity
on the relative enzyme activity, by incubating a serum
with a known activity (15 //moles/1000 m//min at
37°) at different dilutions (fig. 6). This experiment
revealed that enzyme activities up to 15 /jmoles/
1000 m//rnin at 37° (y-glutamyl peptidase and y-gluta-
myl transpeptidase) are linear for a period of 4 hrs.
Lower activities retain their linearity for much longer"
periods of time, up to 48 hrs. The observation is in
agreement with the curve in figure 3, and permits
Tab. 1
The effect of different concentrations (v/v) of propylene glycoi on the
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Tab. 2


















































determination of low hydrolytic and transpeptidase
activities by prolongation of the incubation time. For
example enzyme activities in cerebrospinal fluid can be
measured after an incubation period of 24 hrs (15, 16).
G. Dilution fluid and colour intensity
In order to permit direct colorimetric measurements
after incubation without deproteinization and without
possible loss of the liberated <x-naphthylamine, various
diluents were evaluated. A mixture of propylene
glycol/methanol/water (10:45:45; v/v) dilutes the
reaction mixture indefinitely without causing turbidity.
Of course, the blank must be treated identically. The
optimum composition of this mixture is revealed from
tables 1 and 2.
H. The diazo reagent
The effect of various compositions of the diazo reagent
on the colour intensity was investigated, and is shown
in tables 3 and 4, where the optimal composition is
outlined.
Tab. 3
The effect of different concentrations (v/v) of sodium nitrite on the
extinction of the test solution






















The effect of different concentrations (v/v) of sulphanilic acid solution
on the extinction of the test solution

























I. Sensitivity and reproducibility of the method
When 0.1 //M #-naphthylamine was diazotized ac-
cording to GRIESS (12) or after.BRATTON-MARSHALL,
as described by ORLOWSKI and SZEWCZUK (7) with the
same end volume (6.0 mT), the extinction at 535 nm
was 0.56 and 0.48 respectively. Although the direct
diazotation after GRIESS is more sensitive than that
after BRATTON-MARSHALL, the difference is not sig-
nificant. The reproducibility of both diazotation
methods is good; the maximal deviation with the
GRIESS method lies at O. IX = 0.01 and with the
BRATTON-MARSHALL procedure by O. D. = 0.02.
Because of the greater number of manipulations in-
volved in the latter technique, we have adopted the
former for our procedure.
Clinical Results
A. Normal values
Using this method and the two substrates described
above, the following values for serum were obtained
in a normal population of:
Adults (2 487 cases)
— peptidase activity and internal transpepti-
dation:
mean value: 4.5//moles/1000 m//min at 37°; S. D.
±1.52
(range from 1.5 to 7.5//moles/1000 m//min at 37°).
— transpeptidase activity:
mean value: 6.3//moles/1000 m//min at 37°; S. D.
±2.11
(range from 2.1 to 10.5 //moles/1000 m//min at 37°).
Children up to age 6 years (432 cases)
— peptidase activity and internal transpepti-
dation:
mean value: 2.5//moles/1000 m//min at 37°; S. D.
±0.75
(range from 1.0 to 4.0//moles/1000 m//min at 37°).
— transpeptidation activity:
mean value: 3.5//moles/1000 m//min at 37°; S. D.
± 1.05
(range from 1.5 to 5.7//moles/1000 m//min at 37°).
B. Results
High y-glutamyl transpeptidase activities (with or
without added glycyl-glycine) were found in cases of
cirrhosis, in obstructive jaundice (of different origin),
intrahepatic damage of the bile canniculi or atresia of
the external bile ducts, as well in the extrahepatic
obstruction by cholelithiasis. The serum enzyme
activity becomes higher as the occlusion becomes more
complete. Surgical intervention in cases of choleli-
thiasis normalizes the y-glutamyl transpeptidase activity
in a few days or weeks.
In patients with lithiasis of the bile bladder, without
obstruction of the bile ducts, the serum enzyme activity
was mostly normal or unspecifically increased '(up to
20//moles/1000 m//min/37°). In cases, such as chol-
angitis, were any narrowing of the bile ducts by mucus
or by cells can be suspected, moderately increased
serum y-glutamyl transpeptidase activities were found.
All patients with viral, drug or chronic hepatitis, had
a increased y-glutamyl transpeptidase activity, ranging
from 15.1 to 45.1 //moles/1000 m//min 37°.
There is an overlap in the activity from one disease to
another and table 5 gives the range of values of the
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Tab. 5
Serum y-glutamyl transpeptidase activity expressed as #™J*S/
1000m//mln at 37°, without added glycylgiycine in some diseases
Number Ranging Mean


































16.2 — 37.4 26 5.3
40.0 — 250 145 52.5




1.4 — 2.8 2.1 0.35
15.1 —41.9 28.5 6.7
17.9 — 45.1 31.5 6.8
10.0 — 70.4 40.2 15.1
40.3—104.7 72.5 16.1
• resp. 14 and 16.8
resp. 112—118 and 150
37.2—175 106 34.5
y-glutamyl transpeptidase activities in some diseases.
The y-glutamyl transpeptidase activity was also deter-
mined in the cerebrospinal fluid (15, 16). Evidence was
found that an increased enzymic activity in the cere-
brospinal fluid was independent of the total protein
content, the number of the cells or the clinical symto-
mology, but it was subsequent to brain damage.
When the serum enzyme activity, measured without
added glycyl-glycine (y-glutamyl peptidase and internal
transpeptidation) was called 100%, the enzyme activity
in the presence of 100 mg added glycyl-glycine (y-
glutamyl transpeptidase) showed an average of 140%.
That means that the addition of glycylglycine, caused
an average 40% activation of the total activity. An
exception was found in the serum of 4 patients with
myopathia, for which no activation by glycyl-glycine
could be detected. In one individual the activation by
glycylglycine was not constant but changed with time.
The highest percentage activation was found at the
beginning of any acute process involving the liver,
such as a viral or a drug hepatitis, where an activation
of up to 400% was noted in certain cases.
In cases, which showed no spectacular changes of the
y-glutamyl transpeptidase activity, e. g., in cases of
cirrhosis, there was also no high degree of- activation
by glycylglycine. In other cases, such as in liver cancer
or in obstructive jaundice, in which the y-glutamyl
transpeptidase reached a maximum activity in the
course of time, the activation maximum by glycylgly-
cine coincides with the peptidase activity maximum.
Analogous observations were made for the cerebrospinal
fluid, where the activation by glycylglycine, is highest
in cases of acute cell damage.
Discussion
The highest serum y-glutamyl transpeptidase activity
was found in anicteric patients, with liver metastases,
followed by icteric patients with hepatic neoplasms or
obstructive jaundice of diverse origin. The more
complete the obstruction, the higher was the serum
y-glutamyl transpeptidase activity. In our experience,
the increase of the serum y-glutamyl transpeptidase
activity is a specific and very sensitive index of any
cholestasis.
Liver damage and obstruction give an acceptable
explanation for the observations made with the sub-
strate without added acceptor. However, it does not
explain the differences noted, ^n the activation in the
presence of a constant quantity of added glycylglycine.
On the other hand, there are the observations of DIMOV
and KULHANEK (19), who noted a relative activity of
165% for normal sera and 138% for pathological sera
with the α-naphthylamine method in the presence of
glycylglycine in comparison to its absence. These
authors explain these statistical differences by the
"heterogeneous form of the enzyme, from which some
may be activated more than others. Further the sub-
strate itself may be split more readily by one iso-enzyme
than by others. The differences in pathological sera
may be caused by the different iso-enzyme patterns of
the individual organs and the final relation between
iso-enzymes would then affect the results. Besides,
there is also the possibility that the activity of hetero-
geneous forms of y-glutamyl transpeptidase may be,
in different ways, influenced by ethio-pathogenic
factors in various diseases."
SZCZEKLIK and coworkers (9) supposes "a higher rate
of synthesis of the enzyme as an adaptive response to
the pathological changes in these diseases and an over-
flow of the enzyme into the blood stream."
Without rejecting any of these hypotheses, proposed
by others, we would nevertheless look for an explanation
in the observations made by SZEWOZUK (20). This
author demonstrated the presence, in both the liver
and the kidney, of a microsomal (insoluble) enzyme,
which is related to the soluble (free) form, which
occurs in serum.
They also could present evidence that, particularly in
the liver, the microsomal enzyme may be transformed
into the soluble state during incubation of liver homo-
genates.
In view of these observations, there is good evidence
that the increased activation in the presence of glycyl-
glycine, during the acute phase of an hepatitis, is an.
increased (enzymic?) conversion of the microsomal
enzyme to the soluble form and that the transpepti-
dation activity increases more readily than the pepti-
dase.
With this hypothesis it is possible to explain the in-
crease of the serum y-glutamyl transpeptidase activity
as the result of necrosis of the cells and the solublisation
of the microsomal enzyme(s) on the one hand, and the
intra-or extra-hepatic obstruction on the other.
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